Press Releases - 2023-04-24

Date	Title	Company
24-Apr-2023	General Anesthesia Drugs Market to reach a valuation of US$ 6.7 Billion by the year 2032 \| FMI	MARKITWIRED
24-Apr-2023	The breathing circuits market in Germany is set to expand at a CAGR of 4.0% from 2022 to 2032	MARKITWIRED
24-Apr-2023	Bariatric Beds Market is likely to capture a 5.3% CAGR from 2023 to 2033 \| FMI Study	MARKITWIRED
24-Apr-2023	Primary Hyperoxaluria Treatment Market is anticipated to grow with an 8.6% CAGR from 2023 to 2033 \| FMI Study	MARKITWIRED
24-Apr-2023	Unit Dose Manufacturing Market is projected to reach US$ 164 Billion by 2032	MARKITWIRED
24-Apr-2023	Real World Evidence Solutions Market is expected to surpass US$ 110 billion by 2032	MARKITWIRED
24-Apr-2023	Interventional Cardiology Devices market is likely to register CAGR of 8.4% through 2032	MARKITWIRED
24-Apr-2023	Neurosurgery Surgical Power Tools Market is anticipated to reach US$ 1.99 Billion by 2032, with a CAGR of 4.5%	MARKITWIRED
24-Apr-2023	Esophagoscopes and Gastroscopes Market is slated to progress at a CAGR of 5.4% from 2023 to 2033	MARKITWIRED
24-Apr-2023	Phenylketonuria Therapeutics Market is projected to grow with an 8.6% CAGR from 2023 to 2033 \| FMI	MARKITWIRED
24-Apr-2023	Optic Neuropathy Management Market value of US$ 7 Billion by registering a CAGR of 5% from 2023 to 2033	MARKITWIRED
24-Apr-2023	Barrett’s Esophagus with Dysplasia Treatment Market is projected to grow with a 5.3% CAGR during 2023 to 2033	MARKITWIRED
24-Apr-2023	Severe Hypertriglyceridemia (SHTG) Treatment Market value of US$ 2675.37 Million by registering a CAGR of 14.3% from 2023 to 2033	MARKITWIRED
24-Apr-2023	Defence Therapeutics Inc.: DEFENCE GRANTED US PATENT WITH BROAD COVERAGE ON ACCUMTM-BASED VACCINE ENHANCER PLATFORM TECHNOLOGY	Defence Therapeutics Inc.
24-Apr-2023	Evolva publishes timeline of the Reverse Stock Split	Evolva Holding SA
24-Apr-2023	Cold Disposable Biopsy Forceps Market is expected to enjoy a valuation of US$ 634.6 Million by 2023, at a CAGR of 8.2% from 2023 to 2033	MARKITWIRED
24-Apr-2023	Sales of nasal antihistamines in Japan and South Korea are projected to grow at 5.3% and 3.8% CAGR respectively through 2031.	MARKITWIRED